North America Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Livestock Vaccines [Bovine Vaccines and Small Ruminant Vaccines], Companion Animal Vaccines [Feline Vaccines, Canine Vaccines, and Others], and Others) and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)
Market Introduction
The North American veterinary vaccines market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North American veterinary vaccines market in 2021. Livestock groups provide consumers with different products and services, including meat, milk, eggs, fiber, and draught power. Viral infection among livestock, compassion animals, and others is a critical aspect of animal health in the country. The viruses infecting the animals spread at a faster rate. Thus, immunizations of the animal from such viruses are of prime importance in animal healthcare in the country. The outbreak of the COVID19 pandemic has triggered the vaccination of the animals for the COVID19. For instance, in March 2021, orangutans and bonobos at the San Diego Zoo have received a coronavirus vaccine. Moreover, the regulatory agencies in the country have very stringent policies on controlling the spread of infection among animals and humans. As part of such policies, the agencies have adopted various strategies. For instance, in June 2021, the US has banned the import of dogs from 113 Countries After Rising In False Rabies Records. In addition, in 2020, the CDC identified more than 450 dogs imported in the US with falsified or fraudulent rabies certificates, which was estimated to be about a 52% increase compared with the previous couple of years. Vaccination of the pet is mandatory as part of the routine healthcare plan for the pet and livestock animals. There has been a considerable rise in awareness about the vaccination among the owners of the animals country, the increasing prevalence of viral infections, and the presence of prominent market players based in the is expected to augment the growth of Veterinary Vaccines market during the forecast years.
In case of COVID-19, North America, especially the US, is highly affected. The incidence of COVID-19 has been registered in the animals. Also, there has been an instance where companion animals are infected through their human counterparts. As per the CDC, animals have been infected with SARS-CoV-2, which has been documented in different locations worldwide. The majority of these animals are infected after coming in contact with COVID-19 infected owners, caretakers, and others in close contact with the animals. The infected animals include companion animals (including pet cats, dogs, ferrets), animals at zoos and sanctuaries (different types of big cats, otters, non-human primates, a binturong, a coatimundi, a fishing cat, and hyenas), and minks on mink farms. As a preventive measure, various organizations vaccinate the animals for COVID-19 infection. For instance, in October 2021, Cincinnati Zoo vaccinated about 80 animals against COVID-19 with two doses of a COVID-19 vaccine designed for veterinary use. The COVID-19 pandemic has considerably impacted animal health in the region. The regional players operating in the veterinary vaccines market are actively involved in the production and product innovations. Moreover, it positively impacts the veterinary vaccine market by offering potential business opportunities to the market players. Regional governments are offering support to enhance the animal health-related businesses in the region.
Market Overview and Dynamics
The North America veterinary vaccines market is expected to grow from US$ 3,721.85 million in 2021 to US$ 5,884.41 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The veterinary care business is witnessing substantial transformations. Countries across the region have favored sophisticated remedies and supplements that are simple to use and beneficial in healthcare. Countries across the region are projected to be among the biggest contributors to this expansion in veterinary healthcare. The increasing rate of pet ownership, rising disposable income of the population, and growing awareness related to pet health are among the factors that are likely to drive the growth of the market in the future. Further, improvement in animal welfare across the countries and implementation of rules for the manufacturing of animal vaccines and nutritional supplements would propel the growth of the market in emerging countries in the coming years. There has been a movement in the business approach of animal health enterprises that have grown from medicines to preventive to productivity enhancement and now to total healthcare of the animals. This is expected to increase the adoption of veterinary vaccines in the potential market and several countries, which is projected to create lucrative opportunities for North America market growth during the forecast period.
Key Market Segments
In terms of vaccine type, the livestock vaccines segment accounted for the largest share of the North America veterinary vaccines market in 2020. In terms of technology, the live attenuated vaccines segment held a larger market share of the North America veterinary vaccines market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America veterinary vaccines market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BIOVAC; Boehringer Ingelheim International GmbH; Ceva; Elanco; HIPRA; Merck & Co., Inc.; NEOGEN Corporation; Virbac; and Zoetis Inc. among others.
Reasons to buy report
- To understand the North America veterinary vaccines market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America veterinary vaccines market
- Efficiently plan M&A and partnership deals in North America veterinary vaccines market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America veterinary vaccines market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Veterinary Vaccines Market Segmentation
North America Veterinary Vaccines Market - By Vaccine Type
- Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
- Companion Animal Vaccines
- Feline Vaccines
- Canine Vaccines
- Others
- Others
North America Veterinary Vaccines Market - By Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
- Others
North America Veterinary Vaccines Market - By Country
- US
- Canada
- Mexico
North America Veterinary Vaccines Market - Company Profiles
- BIOVAC
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- HIPRA
- Merck & Co., Inc.
- NEOGEN Corporation
- Virbac
- Zoetis Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Veterinary Vaccines Market – By Vaccine Type
1.3.2 North America Veterinary Vaccines Market – By Technology
1.3.3 North America Veterinary Vaccines Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Veterinary Vaccines Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Veterinary Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Incidences of Zoonotic Diseases
5.1.2 Accelerating Prevalence of Foodborne Diseases and Infections
5.2 Market Restraints
5.2.1 Stringent Government Rules Related to Usage of Veterinary Vaccines
5.3 Market Opportunities
5.3.1 Burgeoning Growth in Untapped Economies
5.4 Future Trends
5.4.1 Growing Awareness of Diagnosis and Treatment of Variety of Infectious Diseases
5.5 Impact Analysis
6. Veterinary Vaccines Market– North America Analysis
6.1 North America Veterinary Vaccines Market Revenue Forecast and Analysis
7. North America Veterinary Vaccines Market Revenue and Forecasts to 2028– By Vaccine Type
7.1 Overview
7.2 North America Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
7.3 Livestock Vaccines
7.3.1 Overview
7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Bovine Vaccines
7.3.3.1 Overview
7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Small Ruminant Vaccines
7.3.4.1 Overview
7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Companion Vaccines
7.4.1 Overview
7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Feline Vaccines
7.4.3.1 Overview
7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Canine Vaccines
7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Other Companion Animal Vaccines
7.4.5.1 Overview
7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Others:
7.5.1 Overview
7.5.2 Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Veterinary Vaccines Market Revenue and Forecasts to 2028 – By Technology
8.1 Overview
8.2 North America Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.6 Recombinant Vaccines
8.6.1 Overview
8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
9. North America Veterinary Vaccines Market Revenue and Forecasts to 2028 – Country Analysis
9.1 North America: Veterinary Vaccines Market
9.1.1 Overview
9.1.3 North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.1.3.1 US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1.1 US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1.2 US: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.3.1.2.1 US: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.3.1.2.2 US: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.3.1.3 US: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.1.3.2 Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.2.1 Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.2.2 Canada: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.3.2.2.1 Canada: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.3.2.2.2 Canada: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.3.2.3 Canada: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
9.1.3.3 Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.1 Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.2 Mexico: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)
9.1.3.3.2.1 Mexico: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)
9.1.3.3.2.2 Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)
9.1.3.3.3 Mexico: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)
10. Impact of COVID-19 Pandemic on North America Veterinary Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zoetis Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Virbac
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BIOVAC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NEOGEN Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 HIPRA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ceva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. US Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Veterinary Vaccines Market, by Companion Animal Vaccines– Revenue and Forecast to 2028 (US$ Million)
Table 5. US Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Veterinary Vaccines Market Segmentation
Figure 2. North America Veterinary Vaccines Market, By Country
Figure 3. North America Veterinary Vaccines Market Overview
Figure 4. Livestock Vaccines Segment Held the Largest Share of the Market in 2021
Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to North America Veterinary Vaccines Market
Figure 9. North America Veterinary Vaccines Market – Forecast and Analysis to 2028
Figure 10. North America Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
Figure 11. North America Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. North America Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. North America Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. North America Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. North America Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. North America Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
Figure 20. North America Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. North America Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. North America Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. North America Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. North America Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. North America: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 26. North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 27. US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Impact of COVID-19 Pandemic in North American Country Markets
CONTACT US
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: info@theinsightpartners.com
DISCLAIMER
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.
- BIOVAC
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- HIPRA
- Merck & Co., Inc.
- NEOGEN Corporation
- Virbac
- Zoetis Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America veterinary vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America veterinary vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the veterinary vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution